ArticleCancers2022

RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines.

Marta Albanell-Fernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.